
ãã¡ãŠãããœãŒã·ã£ã«ãã£ã¹ã¿ã³ã¹ã«æ ¹æ ã¯ãªããšèªãã æŠæŒ¢ç ç©¶æã®ãªãŒã¯ä»®èª¬ã¯é°è¬è«ã§ã¯ãªã
å èšäºã¯ãã¡ããã/Click here to read the original article.
æŠæŒ¢ã³ãããŠã€ã«ã¹ïŒCOVID-19ïŒãã³ãããã¯å¯Ÿçã«ãããç±³åœã®é¡ã§ãã£ãã¢ã³ãœããŒã»ãã¡ãŠãåãã¯ã€ãããŠã¹æé«å»çé¡§åããäžé¢ã³ãããŠã€ã«ã¹ãã³ãããã¯ç¹å¥å°å§å¡äŒã§ã®2æ¥ç®ã®éå
¬é蚌èšãçµããã圌ã¯ãŸããç 究宀ã®ãªãŒã¯ä»®èª¬ãé°è¬è«ã§ã¯ãªãããšãæçµçã«èªããã
ãã©ããã»ãŠã§ã³ã¹ãã©ããå§å¡é·ïŒå
±åå
ïŒã¯ãå
åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æïŒNIAIDïŒæé·ãšã®é¢è«åŸã声æãçºè¡šãããã2æ¥éã«ããã蚌èšãš14æéã«ããã質çã®çµæãå€ãã®ããšãæããã«ãªã£ãã仿¥ã®äºæ
èŽåã§ããã¡ãŠãå士ã¯ããã°ãã°æå§ãããŠããå®éšå®€æµåºä»®èª¬ã¯ãå®éã«ã¯é°è¬è«ã§ã¯ãªãã£ããšèšŒèšããããšãŠã§ã¹ãã«ããæ°ã¯è¿°ã¹ãã
ðšDR. FAUCI TESTIMONY TAKEAWAYSðš@COVIDSelect has completed a two-day, 14-hour transcribed interview with Dr. Anthony Fauci.
â Select Subcommittee on the Coronavirus Pandemic (@COVIDSelect) January 10, 2024
Here are the most important highlights from DAY 2 of his testimonyð
ãã®åçœã¯ãã©ãã»ãªãŒã¯ä»®èª¬ãäžå·ãå蚌ããããšãããä»ã§ã¯æªåé«ããProximal Originãã®åºçãä¿ããŠããçŽ4幎åŸã®ããšã§ãã£ãããŠã§ã¹ãã«ããæ°ã®çºè¡šã«ãããšããã¡ãŠãæ°ã¯ãã®è«æã®äžæ£ç¢ºãªçµè«ãé èœããããã«ããå®éšå®€ããã®æŒåºãã®å®çŸ©ã«æå³æ·±ãªè§£éãå ãããšããã
ããã«ãé£éŠæ¿åºä¿å¥åœå±ãæšé²ãã "6ãã£ãŒãã®è·é¢ã眮ã "瀟äŒçè·é¢ã®æšå¥šã¯ãåŒéããæ¿åºé«å®ãšã®å¯Ÿè©±ã®æžãèµ·ããã«ããã°ã"ãã çŸãã "ãã®ã§ãããç§åŠçããŒã¿ã«åºã¥ããŠããªãã£ãå¯èœæ§ãé«ãã
ãŸãã83æ³ã®ãã¡ãŠãã¯ãCOVID-19ã®ãã³ãããã¯ã®éã«ã¢ã¡ãªã«ãã¯ã¯ãã³æ¥çš®ã矩åä»ããããšããå°æ¥çã«ã¯ã¯ãã³æ¥çš®ãããããããå¯èœæ§ãããããšãèªããŠããã以åã圌㯠ã人ã ã®ç掻ãå°é£ã«ãããšã圌ãã¯ã€ããªãã®ãŒçãªã§ããããã倱ããã¯ã¯ãã³ãæ¥çš®ããããã«ãªã ããšæå±ããŠããããã®ã€ã³ã¿ãã¥ãŒã®ä»ã®ãã€ã©ã€ããšããŠã¯ããã¡ãŠãããã³ãããã¯ã®æäžã«äžå€®æ å ±å±ïŒCIAïŒã蚪åãããšããCOVID-19ã®èµ·æºã«é¢ããCIAã®èª¿æ»ã«åœ±é¿ãäžãããšããçæãåŠå®ããããšãªã©ãããããŸããã¢ã¡ãªã«ã®å€§åŠããã¡ãŠãåå£«ã«æ¥è§Šããéããã¡ãŠãå士ã¯åŠçãã¡ã«ã¯ã¯ãã³æ¥çš®ã矩åã¥ããããã¢ããã€ã¹ãããšããã
ããã¡ãŠãå士ã®èšé²ãããã€ã³ã¿ãã¥ãŒã¯ãããããã®å ¬è¡è¡çã·ã¹ãã ã«ãããäœç³»çãªå€±æãæããã«ããããããã®å ¬è¡è¡çåœå±ã«ãããéå€§ãªæç¶ãäžã®æžå¿µãæããã«ããããšãŠã§ã¹ãã©ããã¯çµè«ã¥ããããå察æèŠããã°ãã°èæ ®ãããªãã£ãããå®å šã«æå§ãããŠããããšã¯æããã§ããå°æ¥ãã³ãããã¯ãçºçããå Žåãã¢ã¡ãªã«ã®å¯Ÿå¿ã¯ç§åŠçäºå®ãšæ±ºå®çããŒã¿ã«ãã£ãŠå°ãããªããã°ãªããªããåè°å¡ã¯ã調æ»ã«ãšã£ãŠéèŠãªCOVID-19ã®æ å ±ããã¡ãŠããæãåºããªãããšã«å§å¡äŒã¯èç«ã£ãŠãããšä»ãå ãããããã«ããããããã圌ã¯ãã¡ãŠããå人çã«èšŒèšããŠãããããšã«æè¬ããŠãããä»å¹Žã®å ¬èŽäŒã§åœŒãšããã«è©±ãããšã楜ãã¿ã«ããŠãããšè¿°ã¹ãã
ãã¡ãŠãã¯ãã³ãããã¯ã®éãæ¿æ²»çã«ååçãªäººç©ãšãªã£ãã圌ã¯ãããã¯ããŠã³ããã¹ã¯èŠåãã¯ã¯ãã³çŸ©ååã«å察ãã人ã ããã¯äžå·ãããäžæ¹ã§æ¿åºã®è¡åã«è³æãã人ã ããã¯å¶ååããããNIAIDã®åæé·ãå ¬ç¶ãšéé£ããŠããã©ã³ãã»ããŒã«äžé¢è°å¡ã¯ããã€ã³ã°ã©ãã ã»ã¢ã³ã°ã«ãã«åºæŒããéããã¡ãŠãã¯åžžã«åœæ°ã«åãã€ããŠãããšèªã£ãããã¢ã³ãœããŒã»ãã¡ãŠãã«ã€ããŠäžè²«ããŠããããšã¯ã圌ããã©ã€ããŒãã§èšã£ãŠããããšã¯ã»ãšãã©çå®ã§ãããå ¬ã®å Žã§èšã£ãŠããããšã¯ã»ãšãã©åã§ãããšããããšã ã
ãã¡ãŠãã¯ãæ©èœç²åŸãã«ç°ãªãå®çŸ©ãäžããŠããã
ãã¡ãŠãã¯ãã©ã³ã·ã¹ã»ã³ãªã³ãºåç±³åœç«è¡çç ç©¶æïŒNIHïŒæé·ãšãšãã«ã2019幎åŸåã«ãã³ãããã¯ãå§ãŸã£ãäžåœã»æŠæŒ¢ã®ç ç©¶æã§å±éºãªæ©èœç²åŸç ç©¶ã«è³éãæäŸããããšãè°äŒã§ã®èšŒèšã§åŠå®ããŠãããããã2023幎6æãæ¿åºèª¬æè²¬ä»»å±ã¯å ±åæžãçºè¡šããæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æãå«ãæ·±å»ãªãã€ãªã»ãŒããã£äžã®æžå¿µã«ãããããããNIHã2014幎ãã2019幎ã®éã«äžåœã®ç ç©¶æ©é¢ã«140äžãã«ä»¥äžãæ åºããŠããããšãæããã«ãããå ±åæžã«ããã°ããã®ç ç©¶ã«ã¯ã倩ç¶ã«ååšããã³ãŠã¢ãªã³ãããŠã€ã«ã¹ãSARSããã³MERSãŠã€ã«ã¹ãšçµåãããéºäŒåå®éšãå«ãŸããŠããããã®çµæãã€ããªããåããïŒãã¡ã©ãšãåŒã°ããïŒã³ãããŠã€ã«ã¹æ ªãçãŸããããšããããã®åŸãã®è³éæäŸã¯æã¡åãããã
æææ¥ã«ãŠã§ã³ã¹ãã«ããã¯ããã¡ãŠãã "æäœç "æ©èœç²åŸç ç©¶ã® "æ°ããå®çŸ© "ãäžãããšèªã£ããããã®çš®ã®ãŠã€ã«ã¹ç ç©¶ãæ±ããã¹ãŠã®ç§åŠè ãããã¡ãŠãã®å®çŸ©ãçè§£ããŠãããšã¯æããŸããããšããã®ãããã®3幎éãæ©èœç²åŸç ç©¶ããã¡ã©ã®äœæã«é¢ããå€ãã®è«æãèªãã§ããããããã¯æ°ãããã®ã ããã§ããããŸããä»ã®å€ãã®ç§åŠè ãæ©èœç²åŸç ç©¶ãå ±åããéã«äœ¿çšãããã®ãšã¯ç°ãªããã
ãããŒã»ãã£ã³ã²ã«äžé¢è°å¡ïŒãã·ã¬ã³å·éžåºïŒã¯å ¬èŽäŒå Žã®å€ã§èšè å£ã«å¯Ÿãããã¡ãŠãã以åããŒã«ãšè¡çªããéã® "éçšäžã® "å®çŸ©ã«ã€ããŠèšåããããšã«è§Šãããããããæã ãããã«ããããšèªäœãããªãæ¿æ²»çãªããšãªã®ã§ãããããšèªã£ããããã圌女ã¯ãéå ¬éã®åœ¢åŒã¯ "å€ãã®çã "ãããããã ãããšè¿°ã¹ããããã®åœ¢åŒã¯ã«ã¡ã©ãããŠããã¶ãã®ã§ã¯ãªããäºå®ãšè©³çްãç¥ãããã®ãã®ã§ãããšãã£ã³ã²ã«ã¯ä»ãå ããã
ãŸãããã¡ãŠããå ¬è¡è¡çåœå±è ãšããŠ40幎è¿ãåšä»»äžãå°çšãåãåã£ãŠããããšãæœåšçãªå©ççžåãå ¬è¡šããŠããªãã£ãããšã«ã€ããŠã質åãããäºå®ã§ãããšå ±éãããã圌ã¯å°çšã¯ãã¹ãŠå¯ä»ãããšäž»åŒµããŠãããã2022幎12æã«å ¬åå¡ãèŸãããšãã®çŽè³ç£ã¯1150äžãã«ã§ãäžæã¯ç±³åœæ¿åºé«å®ã®äžã§æãé«çµŠåãã ã£ãã